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1. Introduction
The evaluation of toxicity is an important process for assessing the hazards and 
risks that diverse xenobiotic released into the environment have for human beings, 
animals, plants and all compartments in our environment. In particular, the toxic 
response at cellular level plays a central role in the identification and quantification 
of adverse outcomes associated with exposure to numerous pollutants, including 
natural toxins, food additives, pesticides, nanomaterials, metals, radiation, viruses, 
biomolecules and medical devices, among others [1–5].
Conventional in vivo testing frequently requires a huge number of animal 
experiments. However, after application of Russel and Burch’s strategy based on 
the ‘3Rs’ – reduction, refinement and replacement – the replacement of animals 
of experimentation for research purposes has been considered, to minimize the 
cruelty and misuse that provoke pain, distress and death experiences [6]. Strategies 
employing specialized animal/human cell lines, tissue cultures, callus cultures, 
organ cultures and the continued use of long-established cultures are an excellent 
and practical way to screen the properties of any xenobiotic in the early stages 
of experimentation. It is well known that in vitro cytotoxicity cannot replace the 
conventional in vivo effects detected in the advanced stages of product development 
but cytotoxic estimation will assist in extrapolating in vitro observations to predict 
or at least to suggest a clue of the in vivo effects [7].
Accurate assessment of the adverse effects of xenobiotics by estimating their 
cytotoxicity as well as their role in different biological systems is a primary step 
employed to rank the safety of many chemicals; knowledge of the relative toxicity is 
essential in order to decide the fate of a chemical to prevent or minimize their effects 
and to identify cytotoxic responses that may be essential for elucidating target cells 
as well as organ toxicity. According to Freshney [8], the meaning of cytotoxicity can 
differ, considering upon the nature of the study and whether cells are killed or simply 
have their metabolism altered. For example, whereas an anticancer drug employed in 
chemotherapy may be required to kill cells, the absence of toxicity in other chemicals 
may involve a deep complete analysis of specific targets such as modifications in cell 
signaling or cell interaction, among other deleterious effects [8].
In recent years, science and technology innovations have accelerated the 
progress in the standardization of methods for determining cytotoxicity that are 
properly sensitive to predict several levels of cell toxicity, i.e., from low to high. 
These bioassays are efficient and economical tools that can quickly make valuable 
responses that are suitable for both qualitative and quantitative assessment [8].
There are numerous as well as highly recommended methodologies routinely used 
for preliminary in vitro screening of cellular response and the analysis of dead cells 
within a cell population. Advantages associated with in vitro approaches are that they 
are easy to follow, less time-consuming and less expensive than other developmental 
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designs [9]. The selection of an appropriate cytotoxicity bioassay is decisive for esti-
mating xenobiotic toxicity and it may be necessary to perform several methodologies 
at the same time to obtain a comprehensive toxicity profile due to numerous sublethal 
cellular changes that may occur after a short period of exposure [10].
Cytotoxic evaluation employs several endpoints such as cell viability, cell cycle 
function and control, cell membrane integrity, DNA synthesis, metabolic side 
effects and apoptosis, among others, as indicators that can potentially help to deter-
mine cellular damage and viability. There are a lot of different methods for estimat-
ing cytotoxicity. Each approach comes with its own set of strengths and weaknesses 
regarding its specificity and sensitivity. Therefore, depending on the study and 
targeted endpoint, an appropriate bioassay should be selected. So far, there is no 
single method alone which has been found to be a suitable indicator of cytotoxicity. 
Several methodologies such as the neutral red uptake (NRU) assay for estimating 
cell viability and membrane damage, the Coomassie blue and Kenacid blue assays 
for measuring cellular proliferation and total protein content, tetrazolium-based 
colorimetric assays as indicators of mitochondrial function, and the cellular leakage 
of lactate dehydrogenase for measuring cell injury are the most commonly and 
habitually employed worldwide [8].
2. Cell viability assays
Numerous cell viability and cell proliferation bioassays are routinely employed 
to analyze the toxicity profile of a xenobiotic on cells cultured in vitro. Estimation of 
the proportion of viable cells relies on an interruption of cellular membrane integrity 
by the incorporation of a dye after a chemical treatment, i.e., dye exclusion and 
preferential dye uptake are frequently employed to distinguish and quantify the pro-
portion of live cells in suspension. Numerous vital dyes, including propidium iodide, 
trypan blue, methylene blue, erythrosine B, nigrosine, eosin, safranin, naphthalene 
black, 7-aminoactinomycin D, and Hoechst 33342 (bis-benzimide H 33342 trihydro-
chloride) have been introduced to estimate the proportion of viable cells [8].
The NRU is the most performed colorimetric bioassay employed to estimate cell 
viability and cytotoxicity. Living cells take up and bind the supravital dye 3-amino-
7-dimethylamino-2-methylphenazine hydrochloride – neutral red – and sequester 
it in the lysosomes and endosomes. The uptake of neutral red depends on the cell’s 
ability to preserve pH gradients, through the production of ATP, and neutral red is 
not retained by dead cells. This bioassay does not estimate the total number of cells, 
but it detects only viable cells [11–13].
The Coomassie blue assay is a methodology employed for determining total 
protein content based on differential binding of the stain by the protein and the 
matrix under acidic conditions. Analysis of cellular proliferation and total protein 
content based on Coomassie blue staining represents a quick, simple, and afford-
able method for detecting cytotoxicity [14]. The cytotoxic effect of xenobiotics 
can be also estimated by modifications in total cell protein by the Kenacid blue dye 
binding assay. The basis of this method is that a test chemical will interfere with this 
process and thus result in a reduction of the growth rate as reflected by cell number. 
The degree of growth inhibition, related to the concentration of the test compound, 
provides an indication of toxicity [15].
The lactate dehydrogenase (LDH) bioassay is another colorimetric methodol-
ogy employed for assaying cellular toxicity. LDH is a cytosolic enzyme present in 
many different cell types and is a well-defined and reliable indicator of cytotoxicity. 
Alterations in the cell membrane provoke the release of cytosolic contents, includ-




can be estimated using a colorimetric assay in which the amount of product formed, 
a tetrazolium salt reduced to a red formazan, correlates to the amount of dead or 
damaged cells [16].
Bioassays that estimate the proportion of viable cells indirectly, by analyzing 
the reduction of the intracellular environment and employing metabolic biomark-
ers, are suitable and offer fewer disadvantages than other available methodologies. 
However, one possible disadvantage of some of these bioassays is that there is no 
distinction between cells that are in proliferation and those that are quiescent, 
which may result in overestimation of the number of analyzed cells. The most rep-
resentative is the metabolic bioassay for estimating ATP (adenosine triphosphate), 
indicative of cell survival and cell growth and determining morphology. ATP is a 
ubiquitous carrier of chemical energy and bioassays that quantify intracellular ATP 
levels indicate cell death [17]. Other metabolic bioassays determine NAD+ (nicotin-
amide adenine dinucleotide) and NADP+ (nicotinamide adenine dinucleotide phos-
phate), two ubiquitous soluble cofactors which are found in cells and implicated 
in energy metabolism, signal transduction and cellular homeostasis. In cells, both 
cofactors are present as oxidized and reduced dinucleotide forms, and changes in 
redox environment are employed to analyze the proportion of viable cells [18].
Metabolic tetrazolium-based colorimetric assays such as the MTT 
(3-(4,5-dimethylthiazol-2-yl)-2–5-diphenyltetrazolium bromide), MTS 
(5-(3-carboxymethoxyphenyl)-2-(4,5-dimethyl-thiazoly)-3-(4-sulfophenyl) tet-
razolium, inner salt assay) and XTT (2,3-bis(2-methoxy-4-nitro-5-sulphophenyl)-
5-carboxanilide-2H-tetrazolium, monosodium salt) bioassays are designed to 
estimate cytotoxicity by measuring the reduction of a colorimetric substrate 
associated not only with mitochondria, by mitochondrial enzymes such as succinate 
dehydrogenase, but also with the cytoplasm and with non-mitochondrial mem-
branes including the endosome/lysosome compartment and the plasma membrane. 
The MTT, MTS and XTT bioassays quantify the proportion of viable cells using a 
colorimetric assay in which the bioreduction of a tetrazolium salt to an intensely 
colored formazan correlates to the amount of dead or damaged cells determined by 
measuring absorbance at 450 nm [19].
3. Perspectives
Cytotoxicity biomarkers have proved most useful as tools to elucidate the 
biochemical and/or metabolic changes involved in the toxic action mechanisms of 
xenobiotics at the cellular level. Many approaches have been optimized and refined, 
more multicentre protocols have been performed and international analysis and 
exchange of information have considerably increased. The increasing collection 
and evaluation of cytotoxic biomarkers is also providing growing opportunities and 
numerous challenges for regulatory toxicity testing, motivating the employment of 
fewer animals of experimentation.
This book, Cytotoxicity, is intended to present the rationale, strategies, methods, 
interpretations and recent advances in in vitro toxicity, presenting both theoretical 
and practical aspects.
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